Rossen Mihaylov at Ramus Medical discusses the challenges faced during the preparation and conduct of clinical investigations. For both medical drugs and devices, CRO...

The major objective of pharmaceutical research & development is to bring new health solutions to people who need them. Lionel Bascles and Victoria (Vicky) DiBiaso...

Clinical trials are becoming increasingly complex, particularly with broader scopes, globalisation, changing and expanding regulatory requirements and a greater numbe...

The first-in-human trial (FIH) is an important milestone in the development of a potential new drug. Nariné Baririan at SGS discusses how going ahead with something t...

Urinary tract infection (UTI) is one of the most common infectious diseases and the most common nosocomial infection in the developed world. Complicated urinary tract...

The National Institute of Aging and Alzheimer’s Association (NIAAA) have recently proposed a common research framework to help investigators establish a research agen...

Cardiopulmonary diseases are major causes of death worldwide, but currently recommended strategies for diagnosis and prevention are believed to be outdated because of...

Acne vulgaris or ‘Pimples' is a very common inflammatory skin disease affecting young adults all over the world, irrespective of race, ethnicity and geographical loca...

Several metrics systems exist to measure performance. The most significant parameters, however, are the course of patient recruitment, how many patients complete the ...

Pharmaceutical manufacturers have long struggled to create an efficient clinical trial process for faster next-phase approval. The root cause of most failures is a la...